| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5741189 | Papillomavirus Research | 2017 | 4 Pages |
Abstract
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
S.M. Garland, J.M.L. Brotherton, A.B. Moscicki, A.M. Kaufmann, M. Stanley, N. Bhatla, R. Sankaranarayanan, S. de Sanjosé, J.M. Palefsky, on behalf of IPVS on behalf of IPVS,